AAREYDRUGS.NSAAREYDRUGS.NSNSE
Loading
Year-over-year operating income growth rate
Percentile
P3
Near historical low
vs 5Y Ago
-1.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -219.97% |
| Q3 2025 | 60.18% |
| Q2 2025 | 135.46% |
| Q1 2025 | -311.84% |
| Q4 2024 | -49.89% |
| Q3 2024 | 25.16% |
| Q2 2024 | 240.55% |
| Q1 2024 | -182.38% |
| Q4 2023 | -1.84% |
| Q3 2023 | 146.38% |
| Q2 2023 | -70.83% |
| Q1 2023 | 117.26% |
| Q4 2022 | -50.06% |
| Q3 2022 | 389.70% |
| Q2 2022 | -149.83% |
| Q1 2022 | -21.13% |
| Q4 2021 | -31.40% |
| Q3 2021 | 47.61% |
| Q2 2021 | 19.40% |
| Q1 2021 | 851.38% |
| Q4 2020 | 129.72% |
| Q3 2020 | -92.47% |
| Q2 2020 | 330.57% |
| Q1 2020 | -152.61% |
| Q4 2019 | 26.45% |
| Q3 2019 | -17.14% |
| Q2 2019 | -50.31% |
| Q1 2019 | 12.98% |
| Q4 2018 | -11.41% |
| Q3 2018 | 99.65% |
| Q2 2018 | -42.58% |
| Q1 2018 | -1.47% |
| Q4 2017 | 9.13% |
| Q3 2017 | -13.26% |
| Q2 2017 | -45.59% |
| Q1 2017 | 66.88% |
| Q4 2016 | 20.31% |
| Q3 2016 | 58.40% |
| Q2 2016 | 51.29% |
| Q1 2016 | 178.30% |